Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1984 Apr;49(4):537–540. doi: 10.1038/bjc.1984.82

Serum thymidine kinase in acute leukaemia.

H Hagberg, S Gronowitz, A Killander, C Källander, B Simonsson, C Sundström, G Oberg
PMCID: PMC1976763  PMID: 6370287

Full text

PDF
539

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bello L. J. Regulation of thymidine kinase synthesis in human cells. Exp Cell Res. 1974 Dec;89(2):263–274. doi: 10.1016/0014-4827(74)90790-3. [DOI] [PubMed] [Google Scholar]
  2. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol. 1976 Aug;33(4):451–458. doi: 10.1111/j.1365-2141.1976.tb03563.x. [DOI] [PubMed] [Google Scholar]
  3. Carpentier N. A., Fiere D. M., Schuh D., Lange G. T., Lambert P. H. Circulating immune complexes and the prognosis of acute myeloid leukemia. N Engl J Med. 1982 Nov 4;307(19):1174–1180. doi: 10.1056/NEJM198211043071903. [DOI] [PubMed] [Google Scholar]
  4. Crowther D., Beard M. E., Bateman C. J., Sewell R. L. Factors influencing prognosis in adults with acute myelogenous leukaemia. Br J Cancer. 1975 Oct;32(4):456–464. doi: 10.1038/bjc.1975.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dosik G. M., Barlogie B., Smith T. L., Gehan E. A., Keating M. J., McCredie K. B., Freireich E. J. Pretreatment flow cytometry of DNA content in adult acute leukemia. Blood. 1980 Mar;55(3):474–482. [PubMed] [Google Scholar]
  6. Ellims P. H., Eng Gan T., Medley G., Van Der Weyden M. B. Prognostic relevance of thymidine kinase isozymes in adult non-Hodgkin's lymphoma. Blood. 1981 Nov;58(5):926–930. [PubMed] [Google Scholar]
  7. Ellims P. H., Gan T. E., Van der Weyden M. B. Thymidine kinase isoenzymes in chronic lymphocytic leukaemia. Br J Haematol. 1981 Nov;49(3):479–481. doi: 10.1111/j.1365-2141.1981.tb07251.x. [DOI] [PubMed] [Google Scholar]
  8. Ellims P. H., Van der Weyden M. B., Medley G. Thymidine kinase isoenzymes in human malignant lymphoma. Cancer Res. 1981 Feb;41(2):691–695. [PubMed] [Google Scholar]
  9. Gehan E. A., Smith T. L., Freireich E. J., Bodey G., Rodriquez V., Speer J., McCredie K. Prognostic factors in acute leukemia. Semin Oncol. 1976 Sep;3(3):271–282. [PubMed] [Google Scholar]
  10. Gronowitz J. S., Hagberg H., Källander C. F., Simonsson B. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma. Br J Cancer. 1983 Apr;47(4):487–495. doi: 10.1038/bjc.1983.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gronowitz J. S., Källander F. R., Diderholm H., Hagberg H., Pettersson U. Application of an in vitro assay for serum thymidine kinase: results on viral disease and malignancies in humans. Int J Cancer. 1984 Jan 15;33(1):5–12. doi: 10.1002/ijc.2910330103. [DOI] [PubMed] [Google Scholar]
  12. Hagberg H., Gronowitz S., Killander A., Källander C. Serum thymidine kinase in vitamin B12 deficiency. Scand J Haematol. 1984 Jan;32(1):41–45. doi: 10.1111/j.1600-0609.1984.tb00675.x. [DOI] [PubMed] [Google Scholar]
  13. Hart J. S., George S. L., Frei E., 3rd, Bodey G. P., Nickerson R. C., Freireich E. J. Prognotic significance of pretreatment proliferative activity in adult acute leukemia. Cancer. 1977 Apr;39(4):1603–1617. doi: 10.1002/1097-0142(197704)39:4<1603::aid-cncr2820390435>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  14. Keating M. J., Smith T. L., Gehan E. A., McCredie K. B., Bodey G. P., Spitzer G., Hersh E., Gutterman J., Freireich E. J. Factors related to length of complete remission in adult acute leukemia. Cancer. 1980 Apr 15;45(8):2017–2029. doi: 10.1002/1097-0142(19800415)45:8<2017::aid-cncr2820450806>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  15. Kreis W., Arlin Z., Yagoda A., Leyland-Jones B. R., Fiori L. Deoxycytidine and deoxythymidine kinase activities in plasma of mice and patients with neoplastic disease. Cancer Res. 1982 Jun;42(6):2514–2517. [PubMed] [Google Scholar]
  16. Lister T. A., Rohatiner A. Z. The treatment of acute myelogenous leukemia in adults. Semin Hematol. 1982 Jul;19(3):172–192. [PubMed] [Google Scholar]
  17. Nakao K., Fujioka S. Thymidine kinase activity in the human bone marrow from various blood diseases. Life Sci. 1968 Apr 15;7(8):395–399. doi: 10.1016/0024-3205(68)90039-8. [DOI] [PubMed] [Google Scholar]
  18. Passe S., Miké V., Mertelsmann R., Gee T. S., Clarkson B. D. Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up. Cancer. 1982 Oct 15;50(8):1462–1471. doi: 10.1002/1097-0142(19821015)50:8<1462::aid-cncr2820500804>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  19. Sewell R. L., Lister T. A., Johnson S. A., Crowther D. Lack of prognostic value of the thymidine-labelling index in adult acute leukaemia. Br J Cancer. 1981 Jul;44(1):55–62. doi: 10.1038/bjc.1981.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Spitzer G., Dicke K. A., Gehan E. A., Smith T., McCredie K. B., Barlogie B., Freireich E. J. A simplified in vitro classification for prognosis in adult acute leukemia: the application of in vitro results in remission-predictive models. Blood. 1976 Dec;48(6):795–807. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES